These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28118838)

  • 1. The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation.
    Kearns B; Rafia R; Leaviss J; Preston L; Brazier JE; Palmer S; Ara R
    BMC Health Serv Res; 2017 Jan; 17(1):78. PubMed ID: 28118838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
    Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
    BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
    Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A
    Value Health; 2010; 13(2):196-208. PubMed ID: 19878493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.
    van Giessen A; Boonman-de Winter LJ; Rutten FH; Cramer MJ; Landman MJ; Liem AH; Hoes AW; Koffijberg H
    Cardiovasc Diabetol; 2016 Mar; 15():48. PubMed ID: 27001409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness Evaluation of Collaborative Care for Diabetes and Depression in Primary Care.
    Johnson JA; Lier DA; Soprovich A; Al Sayah F; Qiu W; Majumdar SR
    Am J Prev Med; 2016 Jul; 51(1):e13-20. PubMed ID: 26947212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study.
    Robotham JV; Deeny SR; Fuller C; Hopkins S; Cookson B; Stone S
    Lancet Infect Dis; 2016 Mar; 16(3):348-56. PubMed ID: 26616206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
    Tunis SL
    Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and economic evaluation of exercise referral schemes in primary care: a short report.
    Campbell F; Holmes M; Everson-Hock E; Davis S; Buckley Woods H; Anokye N; Tappenden P; Kaltenthaler E
    Health Technol Assess; 2015 Jul; 19(60):1-110. PubMed ID: 26222987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of a collaborative care programme for depression in primary care.
    Aragonès E; López-Cortacans G; Sánchez-Iriso E; Piñol JL; Caballero A; Salvador-Carulla L; Cabasés J
    J Affect Disord; 2014 Apr; 159():85-93. PubMed ID: 24679395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of a quality improvement collaborative focusing on patients with diabetes.
    Schouten LM; Niessen LW; van de Pas JW; Grol RP; Hulscher ME
    Med Care; 2010 Oct; 48(10):884-91. PubMed ID: 20808258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of gastric band surgery for overweight but not obese adults with type 2 diabetes in the U.S.
    Wentworth JM; Dalziel KM; O'Brien PE; Burton P; Shaba F; Clarke PM; Laiteerapong N; Brown WA
    J Diabetes Complications; 2017 Jul; 31(7):1139-1144. PubMed ID: 28462893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of a Collaborative Care Depression and Anxiety Treatment Program in Patients with Acute Cardiac Illness.
    Celano CM; Healy B; Suarez L; Levy DE; Mastromauro C; Januzzi JL; Huffman JC
    Value Health; 2016; 19(2):185-91. PubMed ID: 27021752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Costs and Cost-effectiveness of Collaborative Care for Adolescents With Depression in Primary Care Settings: A Randomized Clinical Trial.
    Wright DR; Haaland WL; Ludman E; McCauley E; Lindenbaum J; Richardson LP
    JAMA Pediatr; 2016 Nov; 170(11):1048-1054. PubMed ID: 27654449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of type 2 diabetes screening: results from recently published studies.
    Icks A; Rathmann W; Haastert B; John J; Löwel H; Holle R; Giani G;
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S167-71. PubMed ID: 16032536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression.
    Katon W; Unützer J; Fan MY; Williams JW; Schoenbaum M; Lin EH; Hunkeler EM
    Diabetes Care; 2006 Feb; 29(2):265-70. PubMed ID: 16443871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.
    Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME;
    BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Mental Health in Diabetes Service (MINDS) to enhance psychosocial health: study protocol for a randomized controlled trial.
    O'Brien CL; Ski CF; Thompson DR; Moore G; Mancuso S; Jenkins A; Ward G; MacIsaac RJ; Loh M; Knowles SR; Rossell SL; Castle DJ
    Trials; 2016 Sep; 17(1):444. PubMed ID: 27612943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.